Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting

Niven Mehra(Royal Marsden NHS Foundation Trust), Margreet G.E.M. Ausems(McGill University Health Centre), Winand N.M. Dinjens(Erasmus MC), Walter Noordzij, Ben G.L. Vanneste(Maastricht University Medical Centre), Henk G. van der Poel(Amsterdam University Medical Centers), Roderick van den Bergh(European Association of Urology), Els Dewulf, Maurits Wondergem(The Netherlands Cancer Institute), Ed Schuuring(University Medical Center Groningen), Michel van Kruchten(University Medical Center Groningen), Andries M. Bergman(Oncode Institute), Guido Jenster(Erasmus MC Cancer Institute), Leonie I. Kroeze(Radboud University Nijmegen), Daniela E. Oprea‐Lager(Amsterdam University Medical Centers), R. Jeroen A. van Moorselaar(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jurgen J. Fütterer(Radboud University Nijmegen), Irma M. Oving, Elise M. Bekers(The Netherlands Cancer Institute), Pim J. van Leeuwen(Ghent University Hospital), Steve Boudewijns(Bravis Ziekenhuis), Jack A. Schalken(Radboud University Nijmegen), Shafak Aluwini(Erasmus MC Cancer Institute), Herman Stoevelaar(Barnes-Jewish Hospital), Derya Yakar(Dialyse Centrum Groningen), Erik Vegt(Erasmus MC), Michiel Vlaming(Stabilité génétique et oncogenèse), Ivo G. Schoots(Erasmus MC), Robert Jan Smeenk(Radboud University Nijmegen), Inge M. van Oort(University Medical Center Groningen), André N. Vis(Hôpitaux Universitaires Henri-Mondor), Tom van der Hulle, Wendy W.J. de Leng(University of Pittsburgh), Franchette van den Berkmortel, Rogier A. Oldenburg(Erasmus MC), Chris H. Bangma(Erasmus University Rotterdam), Iris S. H. Kloots(Radboud University Nijmegen), Geert van Leenders, Peter-Paul Willemse(European Association of Urology)
European Urology Open Science
January 25, 2023
10.1016/j.euros.2022.11.011
Cited by 10

Related Papers

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
|Nature Genetics|2002|1.1k
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial
|European Urology|2018|577
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline <i>CDH1</i> mutation carriers
|Journal of Medical Genetics|2015|567